GlassScriptPhysician profile
Pankaj Sharma
NPI 1629366885
$3,136.32
in general payments reported to CMS, 2019-2025
30 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 76% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $141 · 2021: $209 · 2022: $561 · 2023: $202 · 2024: $367 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,098.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rapid Medical LTD | $509.41 | 2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Depuy Synthes Sales INC. | $413.77 | 2025 | Embotrap, Trufill, Cerepak Uniform |
| Stryker Corporation | $353.96 | 2019-2025 | Surpass Evolve |
| Viz.Ai, INC. | $335.14 | 2022 | |
| Medtronic, INC. | $196.11 | 2021-2023 | Pipeline |
| Scientia Vascular | $189.21 | 2023-2024 | Aristotle |
| Imperative Care, INC | $175.53 | 2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Medical Device Business Services, INC. | $137.65 | 2025 | |
| Cook Medical LLC | $113.04 | 2022 | |
| Medtronic USA, INC. | $107.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $88.78 | 2024-2025 | |
| Genentech USA, INC. | $67.84 | 2023-2024 | Ocrevus |
| Ucb, INC. | $53.49 | 2023-2024 | Briviact |
| Alexion Pharmaceuticals, INC. | $47.06 | 2022 | |
| Mallinckrodt Hospital Products INC. | $38.70 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $36.23 | 2022-2023 | Nuplazid |
| Amneal Pharmaceuticals LLC | $31.23 | 2024 | Rytary |
| Emd Serono, INC. | $31.12 | 2022-2023 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $21.08 | 2023 | Ajovy |
| Tg Therapeutics, INC. | $20.90 | 2024 | |
| Genzyme Corporation | $20.22 | 2020 | |
| Tanabe Pharma America, INC. | $19.87 | 2024 | |
| Janssen Pharmaceuticals, INC | $19.78 | 2022 | |
| Argenx US, INC. | $18.41 | 2024 | Vyvgart, Vyvgart Hytrulo |
| Eisai INC. | $18.22 | 2024 | |
| Asahi Intecc USA, INC. | $16.16 | 2025 | Asahi Neurology Wires |
| Neurelis, INC. | $16.11 | 2023 | Valtoco |
| Lundbeck LLC | $13.93 | 2022 | |
| Qapel Medical INC | $12.80 | 2023 | |
| Neurocrine Biosciences, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.